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As the COVID-19 pandemic continues to evolve, we are seeing other emerging public health
threats/emergencies and we continue to address ongoing/emerging disaster issues, the
Center for Disaster Medicine has been and will continue to be a source of reliable information,
education and models for mitigation, preparedness, response, and recovery. As such we are
expanding this informational document to address the broader areas addressed by the center
while retaining critical COVID-19 information. You will notice we have updated the name to
CDM Info Brief. As the pace of new information and changes occur, we will evaluate the
current once per week to determine if this information should be provided on a more frequent
basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

571,188,026

6,386,250

11,931,671,764

United States

90,567,290

1,027,369

597,683,368

New Jersey

2,574,316

34,222

17,871,786

New York

5,786,878

70,125

40,595,440

Connecticut

849,007

11,093

7,932,071

Information as of 7/26/22 at 0300 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
•
•

Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continue to partner with local organizations such as Westchester Department of Emergency
Services and Westchester Medical Center to ensure ongoing collaboration with all public
safety agencies.

•
•
•
•
•
•
•

Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.
On July 21, 2022, CDM staff provided STOP THE BLEED workshop to staff and students of
the NYMC community. This life-saving training is ongoing on a monthly basis so that
everyone has an opportunity to raise their level of awareness and knowledge.

The White House
On July 25, 2022, President Biden is on his fourth day of treatment for SARS-CoV2. His
symptoms are mild at this time and is making good recovery. You can see the full statement
from the physician.
https://www.whitehouse.gov/wp-content/uploads/2022/07/Update-7.25.pdf
On July 23, 2022, Raj Panjabi, Director of White House Pandemic Preparedness Office, issued a
statement on World Health Organization Declaration on Monkeypox- the decision by the World
Health Organization (WHO) to declare the current monkeypox outbreak as a Public Health
Emergency of International Concern is a call to action for the world community to stop the
spread of this virus. A coordinated, international response is essential to stop the spread of
monkeypox, protect communities at greatest risk of contracting the disease, and combat the
current outbreak.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/07/23/statement-from-rajpanjabi-director-of-white-house-pandemic-preparedness-office-on-world-health-organizationdeclaration-on-monkeypox/
On July 19, 2022, President Joe Biden issued a statement regarding the FDA and CDC
Authorizing Novavax’s COVID-19 Vaccine for Adults- Following an independent scientific review
by the Food and Drug Administration last week and today by the Centers for Disease Control
and Prevention, Novavax’s protein-based COVID-19 vaccine for adults has been authorized. We
now have four safe and effective COVID-19 vaccines available to protect Americans against
serious illness, hospitalizations, and death.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/07/19/statement-bypresident-joe-biden-on-fda-and-cdc-authorizing-novavaxs-covid-19-vaccine-for-adults/
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic, provide
economic relief, tackle climate change, and advance racial equity and civil rights, as well as
immediate actions to reform our immigration system and restore America’s standing in the world.
This website will provide all information in one central location.
https://www.whitehouse.gov
COVID-19 Website

On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website
was launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/
Health and Human Services (HHS)
On July 23, 2022, HHS Secretary Xavier Becerra issued a statement regarding the WHO
Decision to Declare Monkeypox a Global Health Emergency – “the declaration by the World
Health Organization is a call to action for the global health community. Monkeypox has spread
around the world and we will continue to take decisive action to tackle it both here in the U.S.
and, working in concert with our partners abroad, globally.”
https://www.hhs.gov/about/news/2022/07/23/statement-from-hhs-secretary-xavier-becerra-onwho-decision-to-declare-monkeypox-global-health-emergency.html
On July 22, 2022, HHS Strengthened Country’s Preparedness for Health Emergencies,
Announces Administration for Strategic Preparedness and Response (ASPR)- The U.S.
Department of Health and Human Services (HHS) announced that Secretary Xavier Becerra has
elevated the existing Office of the Assistant Secretary for Preparedness and Response (ASPR)
from a staff division to an operating division, taking on the new name of the Administration for
Strategic Preparedness and Response (ASPR).
https://www.hhs.gov/about/news/2022/07/22/hhs-strengthens-countrys-preparedness-healthemergencies-announces-administration-for-strategic-preparedness-response.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
On July 20, 2022, the NIH and BARDA issued a statement regarding the Novavax COVID-19
Vaccine- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National
Institutes of Health; the Biomedical Advanced Research and Development Authority (BARDA),
part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for
Preparedness and Response; the Department of Defense (DoD) Joint Program Executive Office
for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND); and the Defense
Health Agency supported the development of NVX-CoV2373 as part of the U.S. government’s
rapid response to develop safe and effective COVID-19 vaccines.
https://www.nih.gov/news-events/news-releases/statement-nih-barda-novavax-covid-19-vaccine
On July 19, 2022, NIH reported a study showing that Vaccine-Induced Immune Response to
Omicron Wanes Substantially Over Time- Although COVID-19 booster vaccinations in adults
elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody
levels decrease substantially within 3 months, according to new clinical trial data. The findings,
published today in Cell Reports Medicine, are from a study sponsored by the National Institute of

Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial was
led by NIAID’s Infectious Diseases Clinical Research Consortium.
https://www.nih.gov/news-events/news-releases/vaccine-induced-immune-response-omicronwanes-substantially-over-time
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
On July 22, 2022, 441 tests and sample collection devices are authorized by the FDA
under emergency use authorizations (EUAs). These include 304 molecular tests and
sample collection devices, 85 antibody and other immune response tests, 51 antigen
tests, and 1 diagnostic breath test. There are 80 molecular authorizations and 1 antibody
authorization that can be used with home-collected samples. There is 1 EUA for a
molecular prescription at-home test, 2 EUAs for antigen prescription at-home tests, 19
EUAs for antigen over-the-counter (OTC) at-home tests, and 3 for molecular OTC athome tests. The FDA has authorized 28 antigen tests and 8 molecular tests for serial
screening programs. The FDA has also authorized 1035 revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-july-22-2022

For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19
Centers for Disease Control and Prevention (CDC)
On July 25, 2022, the CDC provided updated guidance regarding CDC’s ongoing global
response to the COVID-19 pandemic reflects and builds on decades of global health
partnerships. While the world is benefiting from the rapid development and deployment of
effective vaccines, the emergence of variants has further emphasized the importance of
vaccination, boosters, and ongoing prevention efforts to protect against COVID-19. To
contribute to the global goal to vaccinate 70 percent of the world against COVID-19 by the
end of 2022, the United States launched the Initiative for Global Vaccine Access (Global
VAX), a whole-of-government effort to ensure that eligible populations receive COVID-19
vaccines. CDC is a key contributor to Global VAX [PDF, 565K] and is also working to
address inadequate surveillance and laboratory capacity to prevent overburdening of
health systems.
https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/global-response.html
On July 20, 2022, the CDC provided updated guidance regarding Novavax COVID-19,
Adjuvanted Vaccine- Clinical trials demonstrate that Novavax COVID-19 reduces the risk
of COVID-19, including the risk of severe illness and death. However, studies from other
COVID-19 vaccines have shown that protection declines over time especially with the
Omicron variant.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/novavax.html
CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the
characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html
Monkeypox is a rare disease caused by infection with the monkeypox virus. Monkeypox
virus is part of the same family of viruses as variola virus, the virus that causes smallpox.
Monkeypox symptoms are similar to smallpox symptoms, but milder, and monkeypox is
rarely fatal. Monkeypox is not related to chickenpox. For the latest CDC information
including symptoms, testing, vaccines and prevention regarding monkeypox, please visit
https://www.cdc.gov/poxvirus/monkeypox/

According to the CDC, as of July 25, 2022, there are 3,487 cases in the United States.
For the latest monkeypox cases in the United States, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html
According to the CDC, as of July 25, 2022, there are 18,085 cases in the world. For the
latest global monkeypox cases, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
Center for Medicare and Medicaid Services (CMS) +
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page
Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of July 19, 2022, the FDA has granted Emergency Use
Authorization (EUA) to Janssen/Johnson & Johnson for adults over 18 years and
Novavax for adults over 18 years of age and EUA for Moderna and Pfizer for children 6
months to five years. On August 23, 2021, the FDA granted full approval to Pfizer for
adults. On January 31, 2022, the FDA granted full approval to Moderna for adults. Now
with two vaccines with full FDA approval and two vaccines with EUA for adults and
children, the goal is to vaccinate a larger number of persons in the coming months
throughout the United States. As additional vaccines are granted EUA, information for
those vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United States- CDC
provides overall U.S. COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 p.m. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,

and information on how the vaccine works. As of January 31, 2022, the fully FDA
approved Moderna vaccine will now be known as SPIKEVAX for ages 6 months and
older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 6 months and
older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/
Educational Institution Information
•

K-12
•

Clinical Trials

Students may need summer classes to stem learning loss between
school years, but traditional summer school classes have given way to
newer offerings that combine camp-like activities with academic lessons.
Planning these robust summer learning opportunities takes time and
effort to create attractive models students want to try, said Catherine
Augustine, senior policy researcher with the RAND Corp., and one of two
primary investigators for the nonprofit think tank’s National Summer
Learning Project. Augustine added that partnerships to build more
diverse experiences can often vary depending on the region, but the goal
is to find activities that entice students to return every day. These can be
aligned with academics, though programming should more importantly
include options students might not normally have the opportunity to try.
Read more at https://www.k12dive.com/news/schools-eye-moredynamic-summer-programs-to-curb-learning-loss/627737/

To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=
American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
• Governor Kathy Hochul, along with the New York State Department of Health,
announced the distribution of the JYNNEOS vaccine in New York, following an
additional allocation of 8,822 doses to New York State from the federal government.
New York City will receive its own allocation of 23,963 doses directly from the federal
government. "New York continues to face a disproportionate number of monkeypox
cases," Governor Hochul said. "I want to thank President Biden, Dr. Jha and other
Administration officials for their partnership to secure additional vaccines for our state.
While the national supply remains limited, we will continue our efforts to confront this
outbreak with the urgency needed to ensure that New York receives its fair share of
vaccines and protect our most vulnerable communities." In this phase of vaccine
distribution ("2B"), NYSDOH has allocated 2,000 of its doses to New York City, given the
high number of cases concentrated in the area. The rest of the State's allocation will be
distributed to counties based on the number of monkeypox cases in their locality,
proximity to New York City, and ability to reach vaccine-eligible New Yorkers. All doses
in this allocation are recommended to be administered as a first dose of the two-dose
vaccine series. While vaccine supply remains limited, more vaccine is expected in the
coming weeks and months to ensure New Yorkers get both doses needed to be
considered fully vaccinated. https://www.governor.ny.gov/news/governor-hochulannounces-latest-monkeypox-vaccine-distribution-following-2b-allocation
• Governor Kathy Hochul announced new COVID-19 preparedness initiatives to protect
public health and support New York State's ongoing response to the pandemic.
Governor Hochul announced the State is working closely with public health experts to
craft a Fall Action Plan to address the potential for seasonal COVID-19 surges later this
year, as well as strategies to allow students to return safely to school this fall. Governor
Hochul also announced a Request for Proposals has been released for an independent
After-Action Review to assess the State's COVID-19 response, identify what worked and
what did not, and serve as a guide for all local governments planning emergency
response efforts. "Since day one, my top priority has been to keep New Yorkers safe,
especially as we prioritize safely navigating forward through this pandemic," Governor
Hochul said. "My team is working around the clock to bolster our preparedness against
future pandemic surges and other related public health emergencies both in the shortterm and the long-term. We've made real progress in our fight against COVID-19, and
we remain vigilant in making sure that New York State emerges stronger than ever
before." https://www.governor.ny.gov/news/governor-hochul-announces-new-covid-19preparedness-initiatives-protect-public-health-and
• Governor Kathy Hochul announced $387 million is being delivered to 1,452 local
governments across the New York State to help boost their pandemic response
infrastructure. The announcement is part of the State's ongoing preparation efforts to
tackle any potential pandemic-related surges this fall and winter. This financial backing
is made possible by the Coronavirus Local Fiscal Recovery Fund, part of the American
Rescue Plan Act, which provides relief for smaller local governments who have shared

•

in the public health response. https://www.governor.ny.gov/news/governor-hochulannounces-387-million-covid-19-relief-being-delivered-local-governments
Governor Kathy Hochul announced that the New York State Department of Health has
reviewed and approved Quest Diagnostics' recent application for testing to identify
Monkeypox in New York State. The testing, which uses real-time PCR technology to test
samples from individuals who are presenting with vesicular rashes or pustules, will
further expand New York State's ample testing capacity and give providers another
option when it comes to labs that can process samples and detect Monkeypox virus.
Currently, specimens can be tested at the state's Wadsworth Center, the NYC
Department of Health and Mental Hygiene, as well through private labs including
LabCorp, Mayo Clinic, Aegis Sciences Corporation, Sonic Healthcare, and UR Medicine
Lab. "New York still faces a disproportionate number of monkeypox cases, and we will
continue to meet this moment with urgency and aggressive action," Governor Hochul
said. "Today's announcement builds on our ongoing monkeypox response efforts to
expand testing capacity, secure more vaccines and make resources as widely available
as possible. We will continue to do everything in our power to protect New Yorkers,
including our most vulnerable communities." Like other tests available, Quest
Diagnostics' new polymerase chain reaction (PCR) test uses swab specimens collected
by healthcare providers, such as primary care physicians, hospitals or urgent care, from
patients presenting with an acute generalized pustular or vesicular rash. The new type of
testing was announced by Quest in mid-July, with deployment expected in the weeks
ahead. According to New York State Public Health Law, the Department of Health was
required to take additional steps to approve this new testing, with Quest Diagnostics
submitting information to the Clinical Laboratory Evaluation Program (CLEP). That
review is now complete. https://www.governor.ny.gov/news/governor-hochul-announcescontinued-expansion-monkeypox-testing-capacity-approval-quest

New York State Department of Health (DOH)
On July 25, 2022, Governor Hochul announced that the New York State Department of Health
has reviewed and approved Quest Diagnostics' recent application for testing to identify
Monkeypox in New York State. The testing, which uses real-time PCR technology to test
samples from individuals who are presenting with vesicular rashes or pustules, will further
expand New York State's ample testing capacity and give providers another option when it
comes to labs that can process samples and detect Monkeypox virus. Currently, specimens can
be tested at the state's Wadsworth Center, the NYC Department of Health and Mental Hygiene,
as well through private labs including LabCorp, Mayo Clinic, Aegis Sciences Corporation, Sonic
Healthcare, and UR Medicine Lab.
https://www.governor.ny.gov/news/governor-hochul-announces-continued-expansionmonkeypox-testing-capacity-approval-quest
On July 25, 2022, Governor Hochul updated New Yorkers on the state's progress combating
COVID-19. "I remind all New Yorkers to remain vigilant as we continue to respond to COVID19," Governor Hochul said. "Use the tools that we have available and stay up to date on your
vaccine and booster doses, and talk to your child's pediatrician about getting them vaccinated as
soon as possible. If you're traveling or feel unwell, get tested, and if you do test positive, consult
your doctor about treatment options."

https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progresscombating-covid-19-306
On July 22, 2022, Governor Hochul today announced $387 million is being delivered to 1,452
local governments across the New York State to help boost their pandemic response
infrastructure. The announcement is part of the State's ongoing preparation efforts to tackle any
potential pandemic-related surges this fall and winter. This financial backing is made possible by
the Coronavirus Local Fiscal Recovery Fund, part of the American Rescue Plan Act, which
provides relief for smaller local governments who have shared in the public health response.
https://www.governor.ny.gov/news/governor-hochul-announces-387-million-covid-19-reliefbeing-delivered-local-governments
On July 20, 2022, Governor Hochul today announced new COVID-19 preparedness initiatives to
protect public health and support New York State's ongoing response to the pandemic. Governor
Hochul announced the State is working closely with public health experts to craft a Fall Action
Plan to address the potential for seasonal COVID-19 surges later this year, as well as strategies
to allow students to return safely to school this fall. Governor Hochul also announced a Request
for Proposals has been released for an independent After-Action Review to assess the State's
COVID-19 response, identify what worked and what did not, and serve as a guide for all local
governments planning emergency response efforts.
https://www.governor.ny.gov/news/governor-hochul-announces-new-covid-19-preparednessinitiatives-protect-public-health-and
On July 19, 2022, Governor Hochul, along with the New York State Department of Health,
announced the distribution of the JYNNEOS vaccine in New York, following an additional
allocation of 8,822 doses to New York State from the federal government. New York City will
receive its own allocation of 23,963 doses directly from the federal government.
https://www.governor.ny.gov/news/governor-hochul-announces-latest-monkeypox-vaccinedistribution-following-2b-allocation
For a list of COVID-19 positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home
As of July 25, 2022, there are 1,111 cases of monkeypox in New York State. For the latest
monkeypox information including vaccines and provider information from NYS DOH, please visit:
https://www.health.ny.gov/diseases/communicable/zoonoses/monkeypox/

New Jersey
• Governor Phil Murphy and New Jersey Department of Health (NJDOH) Commissioner
Judith Persichilli announced expanded eligibility for the monkeypox vaccine and the
State’s distribution plan for the 2,700 available doses. The vaccine was previously
available to residents with known exposure to a monkeypox case. Going forward, the
JYNNEOS vaccine will also be available to New Jerseyans who are at high risk of
having been exposed to the virus in the past 14 days. There are currently 45 probable
and confirmed cases of the virus in New Jersey.
https://www.nj.gov/governor/news/news/562022/approved/20220719b.shtml
Connecticut
• Governor Ned Lamont today announced the launch of the Connecticut Small Business
Boost Fund, a public-private partnership that provides low-interest loans to small
businesses and nonprofits in Connecticut. Applications are now being accepted for loans
ranging from $5,000 to $500,000. The program is aimed at helping small businesses
and nonprofits, particularly those in low-income and historically underserved
communities, with access to flexible working capital. The loans have a fixed, 4.5 percent
interest rate and are available to eligible small businesses and nonprofits with operations
in Connecticut that have 100 or fewer full-time employees and annual revenues of less
than $8 million. “We’re thrilled to launch the Connecticut Small Business Boost Fund, a
new collaboration with private sector partners and investors that will provide companies
and nonprofits the working capital they need to grow and thrive,” Governor Lamont said.
“This fund was established to support small business owners who may have previously
experienced barriers to accessing financial support and works with and through
community lenders that are dedicated to equitable lending practices.” The state is
making a foundational investment of $75 million into this public-private partnership,
which aims to lend $150 million or more to eligible business and nonprofits. The goal is
for the fund to become self-sustaining as more private funds are invested.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/072022/Governor-Lamont-Announces-New-Loan-Program-for-Connecticut-SmallBusinesses-and-Nonprofits

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
New York City is currently the epicenter of the monkeypox outbreak in the United States. For the
latest information including cases, symptoms, testing and vaccine information regarding monkeypox
in New York City, please visit
https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
NYC DOHMH launched a new COVID-19 variants data page. The data on this page show how
variants of the virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus
with certain sets of mutations. Some variants may result in a COVID-19 infection that is easier to
spread, more severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page

As of July 18, 2022, the NYC DOHMH is re-evaluating its COVID-19 Alert level system. For the
current COVID-19 Alert level in New York City and guidelines, please visit
https://www1.nyc.gov/site/doh/covid/covid-19-alert-levels.page
Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of July 24, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus
As of July 25, 2022, Westchester County has 25 cases of monkeypox.
Monkeypox Vaccine Clinics on Mondays and Wednesdays at 134 Court Street, White Plains.
Appointments are required. People at higher risk for monkeypox infection may consider vaccination
with the two-dose JYNNEOS vaccine.
If you meet the CDC guidance outlined above, you are eligible to register for an appointment at one
of our upcoming Monkeypox Vaccination Clinics. If appointments are unavailable, please check back
regularly as more clinics will be added.
Monkeypox vaccine available on Friday, July 29, by appointment only, at the HOPE Center (4th
floor), Park Care Pavilion, 2 Park Avenue, Yonkers, NY 10703. Individuals must call Lorens Hidalgo
at (914) 964-7725 to schedule the appointment.
For more information regarding monkeypox in Westchester County, please visit
https://health.westchestergov.com/
Putnam County Department of Health
Breakdown of COVID -19 positive cases by towns in Putnam County as of July 22, 2022.
https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/
Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of July 22, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
As of July 25, 2022, there are 3 cases of monkeypox in Dutchess County. For the latest information
regarding monkeypox, please visit
https://www.dutchessny.gov/Departments/DBCH/dbch.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of July 25, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
As of July 25, 2022, there are 2 cases of monkeypox in Orange County. For more information
regarding monkeypox, please visit
https://www.orangecountygov.com/149/Health
Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
July 25, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
As of July 25, 2022, there is 1 case of monkeypox in Rockland County. "The Rockland County
Department of Health is closely monitoring this case, which is limited to just one individual. There is
no identified risk to any county residents. As we have shown with COVID-19, staff at our local
department of health remain vigilant and ready to respond to communicable diseases of all types,
and promptly inform our residents to safeguard their health," said Dr. Ruppert.
For more information regarding monkeypox, please visit Rockland County Health Department
website
https://rocklandgov.com/departments/health/
Healthcare
On July 22, 2022, DOH issues guidance for HCW with Monkeypox and CDC updates Tecoviramat
requirements- GNYHA continues to monitor updated guidance and other developments related to the
monkeypox outbreak. The following includes updated health care worker guidance from the New
York State Department of Health (DOH), changes to the monkeypox therapy protocol, and
clarification about monkeypox-related waste disposal.
https://www.gnyha.org/news/doh-issues-guidance-for-hcw-with-monkeypox-and-cdc-updatestecoviramat-requirements/
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Every effort is made to provide accurate and complete information in this newsletter.
However, New York Medical College cannot guarantee that there will be no errors. NYMC
makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of
the contents of the newsletters or the articles linked herein and further expressly disclaims
liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice.
Always seek the advice of your physician or other qualified health provider with any questions
you may have regarding a medical condition.
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